Dr. Dayan Goodenowe

Dr. Dayan Goodenowe is a globally recognized neuroscientist and chemist, ranking in the top 1% of metabolomics researchers. His extensive research in Alzheimer’s, neurodegeneration, and cancer has redefined the biochemical foundations of disease. He is the inventor of patented diagnostic technologies, a GMP manufacturer, and the best-selling author of Breaking Alzheimer’s.
Since 1990, Dr. Goodenowe has focused on identifying "biochemical prodromes"—molecular deviations that signal health decline before clinical symptoms appear. Through his integrated health technology and education firms, he has developed advanced bioinformatics and restorative training programs for global practitioners.
Most recently, he pioneered the BioMetrix™ Health Technology Suite. This next-generation platform combines advanced brain MRI imaging with BioScan™, an ultra-precision blood analysis. Together, they translate complex biological data into personalized, actionable strategies to restore and optimize health.